lipid nanoparticle
| 6 min read
As soaring costs and logistical complexity strain traditional cell therapy models, in vivo CAR T is prompting a fundamental rethink of how advanced therapies are manufactured and scaled.
| 5 min read
Paolo Martini leads the biotech company’s rare disease research program with the hope of developing the very first treatments for genetic metabolic disorders.
| 5 min read
Scientists developed an alternative to bone marrow transplantation by using technology similar to that of the COVID-19 mRNA vaccines.
| 4 min read
Robert Georgantas aims to expand the development of mRNA-based vaccines for a range of infectious diseases and cancers.
Page 1 of 1 - 4 Total Items
